NEW YORK, Dec. 21, 2023 /PRNewswire/ -- The board of directors (the "Board") of ETAO International Co. Ltd. (the "Company") approved the appointment of Ryoshin Nakade, as ETAO Japan president of the Company, effective on November 22, 2023. Wensheng (Wilson) Liu, Chairman and CEO of ETAO stated, "We are thrilled about ETAO's new appointment of Ryoshin Nakade as ETAO Japan president. With the support of Mr. Ryoshin Nakade, ETAO would scale up its 'Buy Build and Expand' and 'Online Merging Offline 'strategy in Asian market quickly. We hope that in turn would speed up the development and market penetration of ETAO's integrated healthcare services for global customers." ETAO Announces Appointmen
This press release has been corrected to include further details regarding the reverse stock split of ETAO International Co., Ltd. We hereby issue a formal amendment to supersede our previously released press release dated March 19, 2024. This amended communication is intended to replace the original statement in its entirety and provides updated, accurate information. We advise all stakeholders to refer to this latest version for the most current details regarding the matter previously addressed. NEW YORK, March 21, 2024 /PRNewswire/ -- ETAO International Co., Ltd. (the "Company," "we" or "ETAO") (NASDAQ:ETAO), today announced that a 1 for 20 reverse split of its ordinary shares, an increas
NEW YORK, Jan. 12, 2024 /PRNewswire/ -- ETAO International Co. Ltd. announced today that it received a staff determination – Delinquency letter (the "Letter"), on January 5, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company has not yet filed its interim financial statements for the period ended June 30, 2023 (the "Filing"), it no longer complies with our Listing Rules (the "Rules") for continued listing. Accordingly, this matter serves as an additional basis for delisting the Company's securities from The Nasdaq Stock Market. Under Nasdaq rules, a Company that receives a delist determination for delinquency, can request an appea
NEW YORK, Dec. 21, 2023 /PRNewswire/ -- The board of directors (the "Board") of ETAO International Co. Ltd. (the "Company") approved the appointment of Ryoshin Nakade, as ETAO Japan president of the Company, effective on November 22, 2023. Wensheng (Wilson) Liu, Chairman and CEO of ETAO stated, "We are thrilled about ETAO's new appointment of Ryoshin Nakade as ETAO Japan president. With the support of Mr. Ryoshin Nakade, ETAO would scale up its 'Buy Build and Expand' and 'Online Merging Offline 'strategy in Asian market quickly. We hope that in turn would speed up the development and market penetration of ETAO's integrated healthcare services for global customers." ETAO Announces Appointmen
NEW YORK, Dec. 18, 2023 /PRNewswire/ -- ETAO International Co. Ltd. announced today that it received a staff determination letter (the "Letter"), on December 13, 2023, from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company of the determination from the Nasdaq staff (the "Staff") to delist the Company's securities from The Nasdaq Stock Market, because, as of December 11, 2023, the Company has not regained compliance with the bid price requirement as set forth Listing Rule 5550(a)(2) and is not eligible for a second 180 day period. ETAO International Co. Ltd. Received Nasdaq Delisting DeterminationPursuant to the Letter, unless the Company r
NEW YORK, Oct. 12, 2023 /PRNewswire/ -- ETAO International Co. Ltd. announces its plan of reorganization to dispose seven of its twelve consolidated affiliates subsidiaries to trim its operations and improve profitability. On October 11, 2023, pursuant to the terms of the Exclusive Business Cooperation Agreement, ETao Healthcare, the Company's indirectly subsidiary in China, notified Zhichao Medical Technology (Hunan) Co., Ltd., Beijing DNurse Technology Co., Ltd., Kang Ning (Heng Yang) Healthcare Management Co., Ltd., Tianlun (Guiyang) Buyun Buyu Hospital Co., Ltd., Qianhu Medical Management (Jiangxi) Co., Ltd., Chain Workshop (Beijing) Co., Ltd., Baihui (Beijing) Biotech Co., Ltd. and each
NEW YORK, June 22, 2023 /PRNewswire/ -- On June 14, 2023, Etao International Co., Ltd. (the "Company") received a bid price deficiency letter from The Nasdaq Stock Market, LLC ("Nasdaq") notifying the Company that listed securities to maintain a minimum bid price of $1 per share. Based upon the closing bid price for the last 30 consecutive business days, the Company no longer meets this requirement. However, the Rules also provide the Company a compliance period of 180 calendar days in which to regain compliance. If at any time during this 180 day period the closing bid price of the Company's security is at least $1 for a minimum of ten consecutive business days, NASDAQ will provide the Comp
NEW YORK, May 26, 2023 /PRNewswire/ -- On May 18, 2023, Etao International Co., Ltd. (the "Company") received a deficiency letter from The Nasdaq Stock Market, LLC ("Nasdaq") notifying the Company that it no longer complies with Nasdaq's Listing Rule 5250(c)(1) due to its failure to file Form 20-F for the period ended December 31, 2022 (the "Filing"). Nasdaq informed the Company that it has sixty (60) calendar days to submit a plan (the "Plan") to Nasdaq detailing how the Company plans to regain compliance with Nasdaq's continued listing requirements. If Nasdaq accepts the Company's proposed Plan, Nasdaq can grant an exception of up to one hundred-eighty (180) calendar days from the filing's
20-F/A - ETAO International Co., Ltd. (0001939696) (Filer)
6-K - ETAO International Co., Ltd. (0001939696) (Filer)
NT 20-F - ETAO International Co., Ltd. (0001939696) (Filer)
6-K - ETAO International Co., Ltd. (0001939696) (Filer)
20-F/A - ETAO International Co., Ltd. (0001939696) (Filer)
6-K - ETAO International Co., Ltd. (0001939696) (Filer)
6-K - ETAO International Co., Ltd. (0001939696) (Filer)
Gainers CytomX Therapeutics (NASDAQ:CTMX) stock increased by 87.1% to $7.84 during Wednesday's after-market session. The market value of their outstanding shares is at $534.1 million. As per the press release, Q1 earnings came out today. ZimVie (NASDAQ:ZIMV) shares increased by 17.03% to $18.0. The company's market cap stands at $489.9 million. The company's, Q1 earnings came out today. Aesthetic Medical Intl (NASDAQ:AIH) shares moved upwards by 15.0% to $0.53. The market value of their outstanding shares is at $25.2 million. electroCore (NASDAQ:ECOR) shares rose 11.98% to $7.85. The market value of their outstanding shares is at $47.1 million. The company's, Q1 earnings came out today.
Gainers INVO Bioscience (NASDAQ:INVO) shares increased by 93.4% to $1.47 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.8 million. As per the press release, Q4 earnings came out yesterday. Clene (NASDAQ:CLNN) shares moved upwards by 40.8% to $0.44. The market value of their outstanding shares is at $56.0 million. Galera Therapeutics (NASDAQ:GRTX) shares moved upwards by 31.76% to $0.22. The market value of their outstanding shares is at $12.1 million. Vanda Pharma (NASDAQ:VNDA) stock moved upwards by 26.91% to $5.14. The company's market cap stands at $295.7 million. Chromocell Therapeutics (AMEX:CHRO) shares moved upwards by 23.62% to $2.25
Gainers Adial Pharmaceuticals (NASDAQ:ADIL) shares rose 61.6% to $1.83 during Wednesday's regular session. The company's market cap stands at $7.4 million. Jaguar Health (NASDAQ:JAGX) shares rose 32.22% to $0.12. The market value of their outstanding shares is at $32.8 million. Orgenesis (NASDAQ:ORGS) stock rose 27.83% to $0.62. The market value of their outstanding shares is at $21.1 million. BioSig Technologies (NASDAQ:BSGM) shares moved upwards by 15.43% to $1.87. The company's market cap stands at $17.4 million. Etao International Co (NASDAQ:ETAO) shares rose 14.65% to $4.38. The company's market cap stands at $22.4 million. Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 12.84%
Gainers Acrivon Therapeutics (NASDAQ:ACRV) stock moved upwards by 72.3% to $10.19 during Tuesday's pre-market session. The market value of their outstanding shares is at $230.5 million. Biophytis (NASDAQ:BPTS) stock rose 40.64% to $0.45. The market value of their outstanding shares is at $5.1 million. MyMD Pharmaceuticals (NASDAQ:MYMD) stock rose 33.85% to $3.44. The company's market cap stands at $7.1 million. Addex Therapeutics (NASDAQ:ADXN) stock rose 24.48% to $27.2. The company's market cap stands at $28.8 million. Brainstorm Cell (NASDAQ:BCLI) shares rose 21.06% to $0.88. The market value of their outstanding shares is at $60.4 million. Inspire Veterinary (NASDAQ:IVP) shares move
Gainers Etao International Co (NASDAQ:ETAO) stock moved upwards by 96.6% to $4.9 during Monday's regular session. The company's market cap stands at $25.0 million. Longeveron (NASDAQ:LGVN) shares moved upwards by 48.63% to $3.27. The market value of their outstanding shares is at $8.2 million. Adlai Nortye (NASDAQ:ANL) stock rose 47.3% to $12.21. The market value of their outstanding shares is at $450.3 million. Onconetix (NASDAQ:ONCO) stock moved upwards by 26.56% to $0.21. The company's market cap stands at $4.6 million. MSP Recovery (NASDAQ:LIFW) stock rose 24.42% to $1.63. The market value of their outstanding shares is at $24.1 million. Outset Medical (NASDAQ:OM) shares moved upwa
Gainers Longeveron (NASDAQ:LGVN) stock rose 48.6% to $3.27 during Friday's after-market session. The company's market cap stands at $8.2 million. Adial Pharmaceuticals (NASDAQ:ADIL) shares increased by 11.96% to $1.31. The market value of their outstanding shares is at $2.1 million. Etao International Co (NASDAQ:ETAO) stock moved upwards by 11.11% to $2.7. The market value of their outstanding shares is at $13.8 million. 180 Life Sciences (NASDAQ:ATNF) shares rose 7.35% to $2.39. The market value of their outstanding shares is at $1.7 million. Inovio Pharmaceuticals (NASDAQ:INO) stock rose 6.99% to $12.62. The market value of their outstanding shares is at $294.9 million. Gossamer Bio